Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malaria

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 131 articles:
HTML format



Single Articles


    July 2021
  1. ABANYIE F, Acharya SD, Leavy I, Bowe M, et al
    Safety and Effectiveness of Intravenous Artesunate for Treatment of Severe Malaria in the United States -April 2019 through December 2020.
    Clin Infect Dis. 2021 Jul 27. pii: 6329244. doi: 10.1093.
    PubMed     Abstract available


  2. GARRISON A, Boivin MJ, Fievet N, Zoumenou R, et al
    The effects of malaria in pregnancy on neurocognitive development in children at one and six years of age in Benin: a prospective mother-child cohort.
    Clin Infect Dis. 2021 Jul 23. pii: 6326477. doi: 10.1093.
    PubMed     Abstract available


  3. WANGDAHL A, Sonden K, Wyss K, Stenstrom C, et al
    Relapse of Plasmodium vivax and Plasmodium ovale malaria with and without primaquine treatment in a non-endemic area.
    Clin Infect Dis. 2021 Jul 3. pii: 6314296. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  4. DABIRA ED, Hachizovu S, Conteh B, Mendy A, et al
    Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial.
    Clin Infect Dis. 2021 May 13. pii: 6275208. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  5. SUMNER KM, Freedman E, Mangeni JN, Obala AA, et al
    Exposure to diverse Plasmodium falciparum genotypes shapes the risk of symptomatic malaria in incident and persistent infections: A longitudinal molecular epidemiologic study in Kenya.
    Clin Infect Dis. 2021 Apr 27. pii: 6255633. doi: 10.1093.
    PubMed     Abstract available


  6. MAHAMAR A, Andemel N, Swihart B, Sidibe Y, et al
    Malaria infection is common and associated with perinatal mortality and preterm delivery despite widespread use of chemoprevention in Mali: an observational study 2010 to 2014.
    Clin Infect Dis. 2021 Apr 13. pii: 6224393. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  7. ZEHNER N, Adrama H, Kakuru A, Andra T, et al
    Age-related Changes in Malaria Clinical Phenotypes During Infancy are Modified by Sickle Cell Trait.
    Clin Infect Dis. 2021 Mar 19. pii: 6178468. doi: 10.1093.
    PubMed     Abstract available


  8. KAMALIDDIN C, Sutherland CJ, Houze S, Cottrell G, et al
    The role of ultra-sensitive molecular methods for detecting malaria - the broader perspective.
    Clin Infect Dis. 2021 Mar 9. pii: 6164943. doi: 10.1093.
    PubMed     Abstract available


  9. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions.
    Clin Infect Dis. 2021 Mar 2. pii: 6157008. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  10. KITABI E, Bensman TJ, Earp JC, Chilukuri DM, et al
    Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: FDA Basis for Dose Determination of Artesunate for Injection in Pediatric Patients with Severe Malaria.
    Clin Infect Dis. 2021 Feb 19. pii: 6144983. doi: 10.1093.
    PubMed     Abstract available


  11. ROUSSEL C, Ndour PA, Kendjo E, Larreche S, et al
    Intravenous artesunate for the treatment of severe imported malaria: implementation, efficacy and safety in 1391 patients.
    Clin Infect Dis. 2021 Feb 13. pii: 6134777. doi: 10.1093.
    PubMed     Abstract available


  12. GILLETTE MA, Mani DR, Uschnig C, Pelle KG, et al
    Biomarkers to distinguish bacterial from viral pediatric clinical pneumonia in a malaria endemic setting.
    Clin Infect Dis. 2021 Feb 3. pii: 6127315. doi: 10.1093/cid/ciaa1843.
    PubMed     Abstract available


  13. AUNG NM, Nyein PP, Kyi MM, Hanson J, et al
    Bacterial Coinfection in Adults With Severe Malaria.
    Clin Infect Dis. 2021;72:535-536.
    PubMed    


  14. WHITE NJ
    Reply to Aung et al.
    Clin Infect Dis. 2021;72:536-538.
    PubMed    


    January 2021
  15. MISCHLINGER J, Dudek V, Ramharter M
    Predictive performance of rapid diagnostic tests for falciparum malaria and its modelled impact on integrated community case management of malaria in sub-Saharan African febrile children.
    Clin Infect Dis. 2021 Jan 28. pii: 6121687. doi: 10.1093/cid/ciaa1942.
    PubMed     Abstract available


  16. PHIRI MD, Cairns M, Zongo I, Nikiema F, et al
    The duration of protection from azithromycin against malaria, acute respiratory, gastro-intestinal and skin infections when given alongside seasonal malaria chemoprevention: secondary analyses of data from a clinical trial in Hounde, Burkina Faso and
    Clin Infect Dis. 2021 Jan 8. pii: 6071007. doi: 10.1093/cid/ciaa1905.
    PubMed     Abstract available


  17. PETERSEN E, Grobusch MP
    Accurate malaria diagnosis: not only essential for malaria case management, but prerequisite for managing febrile disease in the tropics.
    Clin Infect Dis. 2021 Jan 4. pii: 6062465. doi: 10.1093/cid/ciaa1945.
    PubMed    


    December 2020
  18. SAHU PK, Hoffmann A, Majhi M, Pattnaik R, et al
    Brain Magnetic Resonance Imaging Reveals Different Courses of Disease in Pediatric and Adult Cerebral Malaria.
    Clin Infect Dis. 2020 Dec 16. pii: 6035083. doi: 10.1093/cid/ciaa1647.
    PubMed     Abstract available


  19. JOHN CC
    Adults Are Not Big Children: What Brain Magnetic Resonance Imaging Findings Tell Us About Differences in Pediatric and Adult Cerebral Malaria.
    Clin Infect Dis. 2020 Dec 16. pii: 6035081. doi: 10.1093/cid/ciaa1659.
    PubMed    


    September 2020
  20. BERMAN JD
    Treating Severe Malaria.
    Clin Infect Dis. 2020 Sep 30. pii: 5913352. doi: 10.1093.
    PubMed    


  21. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    PubMed     Abstract available


    August 2020
  22. UYOGA S, Wanjiku P, Rop JC, Makale J, et al
    Plasma Plasmodium falciparum Histidine-Rich Protein-2 concentrations in children with malaria infections of differing severity in Kilifi, Kenya.
    Clin Infect Dis. 2020 Aug 9. pii: 5890098. doi: 10.1093/cid/ciaa1141.
    PubMed     Abstract available


    July 2020
  23. YANG H, Wang J, Liu H, Zhao Y, et al
    Efficacy and Safety of a Naphthoquine-Azithromycin Co-Formulation for Malaria Prophylaxis in Southeast Asia: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial.
    Clin Infect Dis. 2020 Jul 20. pii: 5873746. doi: 10.1093/cid/ciaa1018.
    PubMed     Abstract available


    June 2020
  24. SAMUELS AM, Odero NA, Odongo W, Otieno K, et al
    Response to Hamer and Millers' Commentary, "Why did mass test and treat have no effect on malaria prevalence in western Kenya?"
    Clin Infect Dis. 2020 Jun 21. pii: 5860454. doi: 10.1093.
    PubMed    


  25. WHITE NJ
    Bacteremia in adults with severe malaria.
    Clin Infect Dis. 2020 Jun 7. pii: 5854310. doi: 10.1093.
    PubMed    


  26. BUNDI CK, Nalwoga A, Lubyayi L, Muriuki JM, et al
    Iron deficiency is associated with reduced levels of Plasmodium falciparum-specific antibodies in African children.
    Clin Infect Dis. 2020 Jun 7. pii: 5854375. doi: 10.1093.
    PubMed     Abstract available


  27. AUNG NM, Nyein PP, Kyi MM, Hanson J, et al
    Bacterial co-infection in adults with severe malaria.
    Clin Infect Dis. 2020 Jun 6. pii: 5854309. doi: 10.1093.
    PubMed    


    May 2020
  28. PETERSEN E, Picot S
    The end of the artemisinin era - - we should aim at malaria eradication in Asia using free effective treatment.
    Clin Infect Dis. 2020 May 27. pii: 5847809. doi: 10.1093.
    PubMed    


  29. OPOKA RO, Waiswa A, Harriet N, John CC, et al
    Blackwater Fever in Ugandan Children With Severe Anemia is Associated With Poor Postdischarge Outcomes: A Prospective Cohort Study.
    Clin Infect Dis. 2020;70:2247-2254.
    PubMed     Abstract available


    April 2020
  30. HAMER DH, Miller JM
    Why did mass test and treat have no effect on malaria prevalence in western Kenya?
    Clin Infect Dis. 2020 Apr 23. pii: 5824322. doi: 10.1093.
    PubMed    


  31. SAMUELS AM, Odero NA, Odongo W, Otieno K, et al
    Impact of community-based mass testing and treatment on malaria infection prevalence in a high transmission area of western Kenya: A cluster randomized controlled trial.
    Clin Infect Dis. 2020 Apr 23. pii: 5824323. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  32. PHU NH, Day NPJ, Tuan PQ, Mai NTH, et al
    Concomitant bacteremia in adults with severe falciparum malaria.
    Clin Infect Dis. 2020 Feb 28. pii: 5763096. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  33. FROSCH AEP
    Artesunate Versus Quinine: Keeping Our Options Open.
    Clin Infect Dis. 2020;70:288-289.
    PubMed    


    November 2019
  34. JONGO SA, Church LWP, Mtoro AT, Chakravarty S, et al
    Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ Vaccine in Tanzanian adults.
    Clin Infect Dis. 2019 Nov 29. pii: 5647428. doi: 10.1093/cid/ciz1152.
    PubMed     Abstract available


    October 2019
  35. HEALY SA, Murphy SC, Hume JCC, Shelton L, et al
    Chemoprophylaxis vaccination: Phase 1 study to explore stage-specific immunity to Plasmodium falciparum in U.S. adults.
    Clin Infect Dis. 2019 Oct 17. pii: 5588862. doi: 10.1093/cid/ciz1010.
    PubMed     Abstract available


  36. LI K, Xu Y, Liu L, Wu J, et al
    Malaria among UN peacekeepers in The Democratic Republic of the Congo, South Kivu areas, Jan 2016-Jul 2019.
    Clin Infect Dis. 2019 Oct 9. pii: 5584329. doi: 10.1093.
    PubMed    


    September 2019
  37. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    PubMed     Abstract available


  38. HOUNKONNOU CPA, Briand V, Fievet N, Accrombessi M, et al
    Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin.
    Clin Infect Dis. 2019 Sep 12. pii: 5563807. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  39. CASTELLI F
    Waiting for the malaria vaccine. The complex epidemiological transition towards malaria elimination.
    Clin Infect Dis. 2019 Aug 27. pii: 5555349. doi: 10.1093.
    PubMed    


  40. AKECH S, Chepkirui M, Ogero M, Agweyu A, et al
    The clinical profile of severe paediatric malaria in an area targeted for routine RTS,S/AS01 malaria vaccination in Western Kenya.
    Clin Infect Dis. 2019 Aug 26. pii: 5554744. doi: 10.1093.
    PubMed     Abstract available


  41. LIN JT, Parr JB, Ngasala B
    Non-falciparum malaria in Africa and learning from P. vivax in Asia.
    Clin Infect Dis. 2019 Aug 13. pii: 5549499. doi: 10.1093.
    PubMed    


  42. ALKAN ML
    The Importance of Sub-microscopic Diagnosis of Malaria.
    Clin Infect Dis. 2019 Aug 12. pii: 5548923. doi: 10.1093.
    PubMed    


  43. ACHAN J, Reuling I, Yap XZ, Dabira E, et al
    Serologic markers of previous malaria exposure and functional antibodies inhibiting parasite growth are associated with parasite kinetics following a Plasmodium falciparum controlled human infection.
    Clin Infect Dis. 2019 Aug 12. pii: 5546068. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  44. BUI QUANG P, Huynh Hong Q, Tran Thanh D, Le Thanh D, et al
    Pyronaridine-artesunate efficacy and safety in uncomplicated Plasmodium falciparum malaria in areas of artemisinin-resistant falciparum in Viet Nam (2017-2018).
    Clin Infect Dis. 2019 Jun 28. pii: 5525051. doi: 10.1093.
    PubMed     Abstract available


  45. OKOMBO J, Fidock DA
    Pyronaridine-Artesunate Shows Promise as an Effective and Well-Tolerated Treatment for Artemisinin-Resistant Plasmodium falciparum Malaria.
    Clin Infect Dis. 2019 Jun 28. pii: 5524934. doi: 10.1093.
    PubMed    


    May 2019
  46. HSIANG MS, Ntshalintshali N, Kang Dufour MS, Dlamini N, et al
    Active case-finding for malaria: A three-year national evaluation of optimal approaches to detect infections and hotspots through reactive case detection in the low transmission setting of Eswatini.
    Clin Infect Dis. 2019 May 16. pii: 5490610. doi: 10.1093.
    PubMed     Abstract available


  47. DATTA D, Conroy AL, Castelluccio PF, Ssenkusu JM, et al
    Elevated cerebrospinal fluid tau protein concentrations on admission are associated with long-term neurologic and cognitive impairment in Ugandan children with cerebral malaria.
    Clin Infect Dis. 2019 May 2. pii: 5482454. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  48. COOPER DJ, Rajahram GS, William T, Jelip J, et al
    Plasmodium knowlesi malaria in Sabah, Malaysia, 2015-2017: ongoing increase in incidence despite near-elimination of the human-only Plasmodium species.
    Clin Infect Dis. 2019 Mar 19. pii: 5393645. doi: 10.1093.
    PubMed     Abstract available


  49. KARUNAJEEWA H, Berman J
    Is the epidemiology of Plasmodium knowlesi changing and what does this mean for malaria control in South East Asia?
    Clin Infect Dis. 2019 Mar 19. pii: 5386571. doi: 10.1093.
    PubMed    


  50. ELKET N, Kendjo E, Thellier M, Assoumou L, et al
    Propensity score analysis of artesunate versus quinine for severe imported Plasmodium falciparum malaria in France.
    Clin Infect Dis. 2019 Mar 15. pii: 5381062. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  51. AWANDU SS, Raman J, Bousema T, Birkholtz LM, et al
    Ultra-low-density Plasmodium falciparum infections in African settings.
    Clin Infect Dis. 2019 Feb 15. pii: 5320191. doi: 10.1093.
    PubMed    


  52. YEO TW, Weinberg JB, Lampah DA, Kenangalem E, et al
    Glycocalyx Breakdown is Associated with Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.
    Clin Infect Dis. 2019 Feb 12. pii: 5316441. doi: 10.1093.
    PubMed     Abstract available


  53. BRADLEY J, Soumare HM, Mahamar A, Diawara H, et al
    Transmission-blocking effects of primaquine and methylene blue suggest P. falciparum gametocyte sterilisation rather than effects on sex ratio.
    Clin Infect Dis. 2019 Feb 12. pii: 5316265. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  54. GEORGIADOU A, Cunnington AJ
    Shedding of the Vascular Endothelial Glycocalyx - a Common Pathway to Severe Malaria?
    Clin Infect Dis. 2019 Jan 29. pii: 5304008. doi: 10.1093.
    PubMed    


  55. MORDMULLER B, Sulyok M, Egger-Adam D, Resende M, et al
    First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria.
    Clin Infect Dis. 2019 Jan 10. pii: 5281109. doi: 10.1093/cid/ciy1140.
    PubMed     Abstract available


  56. RAJAHRAM GS, Cooper DJ, William T, Grigg MJ, et al
    Deaths from Plasmodium knowlesi malaria: case series and systematic review.
    Clin Infect Dis. 2019 Jan 8. pii: 5280309. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  57. DEJON-AGOBE JC, Ateba-Ngoa U, Lalremruata A, Homoet A, et al
    Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2.
    Clin Infect Dis. 2018 Dec 18. pii: 5252072. doi: 10.1093/cid/ciy1087.
    PubMed     Abstract available


  58. ACCROMBESSI M, Yovo E, Fievet N, Cottrell G, et al
    Effects of Malaria in the First Trimester of Pregnancy on Poor Maternal and Birth Outcomes in Benin.
    Clin Infect Dis. 2018 Dec 18. pii: 5251978. doi: 10.1093/cid/ciy1073.
    PubMed     Abstract available


  59. SCHLAGENHAUF P, Patel D
    <<Who>> <<Where>> and <<Why>> moves to checkmate imported malaria?
    Clin Infect Dis. 2018 Dec 7. pii: 5233130. doi: 10.1093/cid/ciy1044.
    PubMed    


  60. MOYO QM, Besser M, Lynn R, Lever AML, et al
    Persistence of imported Malaria into the UK: an epidemiological review of risk factors and at risk groups.
    Clin Infect Dis. 2018 Dec 7. pii: 5233009. doi: 10.1093/cid/ciy1037.
    PubMed     Abstract available


    November 2018
  61. GIRMA S, Cheaveau J, Mohon AN, Marasinghe D, et al
    Prevalence and epidemiological characteristics of asymptomatic malaria based on ultrasensitive diagnostics: A cross-sectional study.
    Clin Infect Dis. 2018 Nov 26. pii: 5208346. doi: 10.1093/cid/ciy1005.
    PubMed     Abstract available


  62. MCCARTHY JS, Smith B, Reid M, Berman J, et al
    Blood schizonticidal activity and safety of tafenoquine when administered as chemoprophylaxis to healthy, non-immune participants followed by blood stage Plasmodium falciparum challenge: A randomized, double-blinded, placebo-controlled Phase 1b study.
    Clin Infect Dis. 2018 Nov 1. pii: 5154907. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  63. DOBANO C, Nhabomba AJ, Manaca MN, Berthoud T, et al
    A balanced pro-inflammatory and regulatory cytokine signature in young African children is associated with lower risk of clinical malaria.
    Clin Infect Dis. 2018 Oct 31. pii: 5151218. doi: 10.1093.
    PubMed     Abstract available


  64. MWESIGWA J, Achan J, Affara M, Wathuo M, et al
    Mass drug administration with dihydroartemisinin-piperaquine and malaria transmission dynamics in The Gambia - a prospective cohort study.
    Clin Infect Dis. 2018 Oct 10. pii: 5125954. doi: 10.1093.
    PubMed     Abstract available


  65. GULER JL, Rosenthal PJ
    Mass drug administration to control and eliminate malaria in Africa: how do we best utilize the tools at hand?
    Clin Infect Dis. 2018 Oct 10. pii: 5125955. doi: 10.1093.
    PubMed    


  66. LAU CL, Ramsey L, Mills L, Furuya-Kanamori L, et al
    Drug-free holidays: Compliance, tolerability, and acceptability of a 3-day atovaquone/proguanil schedule for pre-travel malaria chemoprophylaxis in Australian travellers.
    Clin Infect Dis. 2018 Oct 3. pii: 5114398. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  67. MURIUKI JM, Mentzer AJ, Kimita W, Ndungu FM, et al
    Iron Status and Associated Malaria Risk Among African Children.
    Clin Infect Dis. 2018 Sep 14. pii: 5096852. doi: 10.1093.
    PubMed     Abstract available


  68. PETO TJ, Tripura R, Maude RJ
    Strengthen village malaria reporting to better target reservoirs of persistent infections in Southeast Asia.
    Clin Infect Dis. 2018 Sep 14. pii: 5096854. doi: 10.1093.
    PubMed    


    August 2018
  69. KURTIS JD, Raj DK, Michelow IC, Park S, et al
    Maternally derived antibodies to Schizont Egress Antigen-1 and protection of infants from severe malaria.
    Clin Infect Dis. 2018 Aug 25. pii: 5079188. doi: 10.1093.
    PubMed     Abstract available


  70. CHU CS, Phyo AP, Turner C, Win HH, et al
    Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
    Clin Infect Dis. 2018 Aug 24. pii: 5079011. doi: 10.1093.
    PubMed     Abstract available


    June 2018

  71. Community-based malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment with Sulfadoxine-pyrimethamine: A Multicentre (The Gambia, Burkina Faso and Benin) Cluster Randomised Controlled Trial.
    Clin Infect Dis. 2018 Jun 29. pii: 5046692. doi: 10.1093.
    PubMed     Abstract available


  72. STEINER-MONARD V, Kamaka K, Karoui O, Roethlisberger S, et al
    The Candidate Blood Stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase I Trial in Exposed and Non Exposed Volunteers.
    Clin Infect Dis. 2018 Jun 26. pii: 5045203. doi: 10.1093.
    PubMed     Abstract available


  73. CHU CS, Phyo AP, Lwin KM, Win HH, et al
    Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
    Clin Infect Dis. 2018 Jun 8. pii: 5034800. doi: 10.1093.
    PubMed     Abstract available


  74. ARINAITWE E, Dorsey G, Nankabirwa JI, Kigozi SP, et al
    Association between Recent Overnight Travel and Risk of Malaria: A Prospective Cohort Study at Three Sites in Uganda.
    Clin Infect Dis. 2018 Jun 4. pii: 5032708. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  75. KHO S, Andries B, Poespoprodjo JR, Commons RJ, et al
    High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia.
    Clin Infect Dis. 2018 May 16. pii: 4996544. doi: 10.1093.
    PubMed     Abstract available


  76. IPPOLITO MM, Jacobson JM, Lederman MM, Winterberg M, et al
    Effect of antiretroviral therapy on plasma concentrations of chloroquine and desethyl-chloroquine.
    Clin Infect Dis. 2018 May 16. pii: 4996547. doi: 10.1093.
    PubMed     Abstract available


  77. BUCHWALD AG, Sixpence A, Chimenya M, Damson M, et al
    Clinical implications of asymptomatic Plasmodium falciparum infections in Malawi.
    Clin Infect Dis. 2018 May 16. pii: 4996917. doi: 10.1093.
    PubMed     Abstract available


  78. AGUAS R, Maude RJ, Gomes MGM, White LJ, et al
    Infectivity of Chronic Malaria Infections and Its Consequences for Control and Elimination.
    Clin Infect Dis. 2018 May 10. pii: 4994834. doi: 10.1093.
    PubMed     Abstract available


  79. TUIKUE NDAM N, Tornyigah B, Dossou AY, Escriou G, et al
    Persistent Plasmodium falciparum infection in women with an intent to become pregnant is a risk factor for pregnancy-associated malaria.
    Clin Infect Dis. 2018 May 4. pii: 4992589. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  80. IPPOLITO MM, Denny JE, Langelier C, Sears CL, et al
    Malaria and the microbiome: a systematic review.
    Clin Infect Dis. 2018 Apr 26. pii: 4986462. doi: 10.1093.
    PubMed     Abstract available


  81. DENG C, Huang B, Wang Q, Wu W, et al
    Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.
    Clin Infect Dis. 2018 Apr 24. pii: 4984633. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  82. SUTANTO I, Kosasih A, Elyazar IRF, Simanjuntak DR, et al
    Negligible Impact of Mass Screening and Treatment on Meso-endemic Malaria Transmission at West Timor in Eastern Indonesia: A Cluster-Randomised Trial.
    Clin Infect Dis. 2018 Mar 22. pii: 4951459. doi: 10.1093.
    PubMed     Abstract available


  83. KEENE CM, Dondorp A, Crawley J, Ohuma EO, et al
    A Competing-Risk Approach to Modelling Length of Stay in Severe Malaria Patients in South-East Asia and the Implications for Planning of Hospital Services.
    Clin Infect Dis. 2018 Mar 19. pii: 4942414. doi: 10.1093.
    PubMed     Abstract available


  84. SAVIC RM, Jagannathan P, Kajubi R, Huang L, et al
    Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine.
    Clin Infect Dis. 2018 Mar 14. pii: 4933916. doi: 10.1093.
    PubMed     Abstract available


  85. GALATAS B, Marti-Soler H, Nhamussua L, Cistero P, et al
    Dynamics of afebrile Plasmodium falciparum Infections in Mozambican Men.
    Clin Infect Dis. 2018 Mar 13. pii: 4931589. doi: 10.1093.
    PubMed     Abstract available


  86. PLEWES K, Kingston HWF, Ghose A, Wattanakul T, et al
    Acetaminophen as a Renoprotective Adjunctive Treatment in Patients with Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.
    Clin Infect Dis. 2018 Mar 12. pii: 4930781. doi: 10.1093.
    PubMed     Abstract available


  87. TRIPURA R, Peto TJ, Nguon C, Davoeung C, et al
    A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multi Drug Resistant Falciparum Malaria in Cambodian Villages.
    Clin Infect Dis. 2018 Mar 7. pii: 4924016. doi: 10.1093.
    PubMed     Abstract available


  88. OLDENBURG CE, Guerin PJ, Berthe F, Grais RF, et al
    Malaria and nutritional status among children with severe acute malnutrition in Niger: a prospective cohort study.
    Clin Infect Dis. 2018 Mar 7. pii: 4924398. doi: 10.1093.
    PubMed     Abstract available


  89. GRIGG MJ, William T, Barber BE, Rajahram GS, et al
    Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of Severity.
    Clin Infect Dis. 2018 Mar 5. pii: 4828216. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  90. HOGAN B, Eibach D, Krumkamp R, Sarpong N, et al
    Malaria Coinfections in Febrile Pediatric Inpatients: A Hospital-Based Study From Ghana.
    Clin Infect Dis. 2018 Feb 2. pii: 4835722. doi: 10.1093/cid/cix1120.
    PubMed     Abstract available


  91. VALMASEDA A, Macete E, Nhabomba A, Guinovart C, et al
    Identifying Immune Correlates of Protection Against Plasmodium falciparum Through a Novel Approach to Account for Heterogeneity in Malaria Exposure.
    Clin Infect Dis. 2018;66:586-593.
    PubMed     Abstract available


    January 2018
  92. SUGIARTO SR, Moore BR, Makani J, Davis TME, et al
    Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.
    Clin Infect Dis. 2018 Jan 23. pii: 4822535. doi: 10.1093.
    PubMed     Abstract available


  93. ROSSI G, Vernaeve L, Van den Bergh R, Nguon C, et al
    Closing in on the Reservoir: Proactive Case Detection in High-Risk Groups as a Strategy to Detect Plasmodium falciparum Asymptomatic Carriers in Cambodia.
    Clin Infect Dis. 2018 Jan 18. pii: 4816713. doi: 10.1093/cid/cix1064.
    PubMed     Abstract available


  94. TADESSE FG, Slater HC, Chali W, Teelen K, et al
    The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia.
    Clin Infect Dis. 2018 Jan 3. pii: 4786592. doi: 10.1093/cid/cix1123.
    PubMed     Abstract available


    December 2017
  95. MOMBO-NGOMA G, Remppis J, Sievers M, Zoleko Manego R, et al
    Efficacy and safety of fosmidomycin-piperaquine as non-artemisinin-based combination therapy for uncomplicated falciparum malaria - A single-arm, age-de-escalation proof of concept study in Gabon.
    Clin Infect Dis. 2017 Dec 26. pii: 4774674. doi: 10.1093/cid/cix1122.
    PubMed     Abstract available


  96. EYAL M, Rahav G, Eli S
    Vivax malaria chemoprophylaxis: the role of Atovaquone-proguanil, compared to other options.
    Clin Infect Dis. 2017 Dec 7. pii: 4706214. doi: 10.1093/cid/cix1077.
    PubMed     Abstract available


    October 2017
  97. BOUAZIZ O, Courtin D, Cottrell G, Milet J, et al
    Is placental malaria a long term risk factor for mild malaria attack in infancy? Revisiting a paradigm.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    PubMed     Abstract available


    September 2017
  98. GRIGG MJ, William T, Barber BE, Rajahram GS, et al
    Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria (CAN KNOW): an open-label randomized controlled trial.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Abstract available


  99. ROSSI G, Van den Bergh R, Nguon C, Debackere M, et al
    Adapting reactive case detection strategies for falciparum malaria in a low-transmission area in Cambodia.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Abstract available


    August 2017
  100. TOURE OA, Mwapasa V, Sagara I, Gaye O, et al
    Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, R
    Clin Infect Dis. 2017 Aug 29. doi: 10.1093.
    PubMed     Abstract available


  101. BOYCE R, Reyes R, Matte M, Ntaro M, et al
    Use of a Dual-Antigen Rapid Diagnostic Test to Screen Children for Severe Plasmodium falciparum Malaria in a High-Transmission, Resource-Limited Setting.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Abstract available


  102. BROOKS HM, Jean Paul MK, Claude KM, Houston S, et al
    Malaria in an Internally Displaced Persons Camp in the Democratic Republic of the Congo.
    Clin Infect Dis. 2017;65:529-530.
    PubMed    


    July 2017
  103. ROSSI G, De Smet M, Khim N, Kindermans JM, et al
    Performances of Rapid Diagnostic Testing in Patients with Suspected Malaria in Cambodia, a Low-Endemicity Country Aiming for Malaria Elimination.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed    


  104. FRIED M, Kurtis JD, Swihart B, Pond-Tor S, et al
    Systemic Inflammatory Response to Malaria During Pregnancy Is Associated With Pregnancy Loss and Preterm Delivery.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Abstract available


    June 2017
  105. TINE RC, Sylla K, Faye BT, Poirot E, et al
    Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
    Clin Infect Dis. 2017 Jun 12. doi: 10.1093.
    PubMed     Abstract available


  106. GRUELL H, Hamacher L, Jennissen V, Tuchscherer A, et al
    On taking a different route: an unlikely case of malaria by nosocomial transmission.
    Clin Infect Dis. 2017 Jun 2. doi: 10.1093.
    PubMed     Abstract available


    May 2017
  107. WYSS K, Wangdahl A, Vesterlund M, Hammar U, et al
    Obesity and Diabetes as Risk Factors for Severe Plasmodium falciparum Malaria: Results from a Swedish Nationwide Study.
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Abstract available


  108. MONCUNILL G, Mpina M, Nhabomba AJ, Aguilar R, et al
    Distinct TH1 and TH2 cellular responses associated with malaria protection and risk in RTS,S/AS01E vaccinees.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Abstract available


  109. BJORKMAN A, Cook J, Sturrock H, Msellem M, et al
    Spatial Distribution of Falciparum Malaria Infections in Zanzibar: Implications for Focal Drug Administration Strategies Targeting Asymptomatic Parasite Carriers.
    Clin Infect Dis. 2017;64:1236-1243.
    PubMed     Abstract available


    April 2017
  110. DAVIS NL, Wiener J, Juliano JJ, Adair L, et al
    Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in HIV-exposed uninfected infants in Malawi: The BAN study.
    Clin Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Abstract available


  111. CHICO RM, Chaponda EB, Ariti C, Chandramohan D, et al
    Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.
    Clin Infect Dis. 2017;64:1043-1051.
    PubMed     Abstract available


  112. IPPOLITO MM, Johnson J, Mullin C, Mallow C, et al
    The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2017 Apr 11. doi: 10.1093.
    PubMed     Abstract available


  113. OLUPOT-OLUPOT P, Engoru C, Uyoga S, Muhindo R, et al
    High Frequency of Blackwater Fever Among Children Presenting to Hospital With Severe Febrile Illnesses in Eastern Uganda.
    Clin Infect Dis. 2017;64:939-946.
    PubMed     Abstract available


    March 2017
  114. NEUMAYR A, Paris D, Genton B, Hatz C, et al
    Artemether-lumefantrine treatment failure in nonimmune European travelers with P. falciparum malaria: 5.3% now and 5.3% then - need to reconsider dosing in patients from non-endemic regions?
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed    


  115. RANADIVE N, Kunene S, Darteh S, Ntshalintshali N, et al
    Limitations of Rapid Diagnostic Testing in Patients with Suspected Malaria: A Diagnostic Accuracy Evaluation from Swaziland, a Low-Endemicity Country Aiming for Malaria Elimination.
    Clin Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  116. RAOUF S, Mpimbaza A, Kigozi R, Sserwanga A, et al
    Resurgence of malaria following discontinuation of indoor residual spraying of insecticide in a previously high transmission intensity area of Uganda.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Abstract available


  117. PORTUGAL S, Tran TM, Ongoiba A, Bathily A, et al
    Treatment of Chronic Asymptomatic Plasmodium falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection.
    Clin Infect Dis. 2017;64:645-653.
    PubMed     Abstract available


    February 2017
  118. DRANCOURT M, Raoult D
    Malaria Therapy for Ebola Virus Infection.
    Clin Infect Dis. 2017 Feb 10. doi: 10.1093.
    PubMed    


  119. WHITE NJ
    The Consequences of Treating Asymptomatic Malaria Parasitemia.
    Clin Infect Dis. 2017 Feb 8. doi: 10.1093.
    PubMed    


  120. SMIT MA, Michelow IC, Glavis-Bloom J, Wolfman V, et al
    Characteristics and Outcomes of Pediatric Patients With Ebola Virus Disease Admitted to Treatment Units in Liberia and Sierra Leone: A Retrospective Cohort Study.
    Clin Infect Dis. 2017;64:243-249.
    PubMed     Abstract available


    January 2017
  121. SIQUEIRA AM, Alencar AC, Melo GC, Magalhaes BL, et al
    Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.
    Clin Infect Dis. 2017;64:166-174.
    PubMed     Abstract available


    December 2016
  122. JEGEDE AS, Oshiname FO, Sanou AK, Nsungwa-Sabiiti J, et al
    Assessing Acceptability of a Diagnostic and Malaria Treatment Package Delivered by Community Health Workers in Malaria-Endemic Settings of Burkina Faso, Nigeria, and Uganda.
    Clin Infect Dis. 2016;63.
    PubMed     Abstract available


  123. CASTELLANI J, Mihaylova B, Ajayi IO, Siribie M, et al
    Quantifying and Valuing Community Health Worker Time in Improving Access to Malaria Diagnosis and Treatment.
    Clin Infect Dis. 2016;63.
    PubMed     Abstract available


  124. FALADE CO, Ajayi IO, Nsungwa-Sabiiti J, Siribie M, et al
    Malaria Rapid Diagnostic Tests and Malaria Microscopy for Guiding Malaria Treatment of Uncomplicated Fevers in Nigeria and Prereferral Cases in 3 African Countries.
    Clin Infect Dis. 2016;63.
    PubMed     Abstract available


  125. SINGLOVIC J, Ajayi IO, Nsungwa-Sabiiti J, Siribie M, et al
    Compliance With Malaria Rapid Diagnostic Testing by Community Health Workers in 3 Malaria-Endemic Countries of Sub-Saharan Africa: An Observational Study.
    Clin Infect Dis. 2016;63.
    PubMed     Abstract available


  126. SIRIBIE M, Ajayi IO, Nsungwa-Sabiiti J, Afonne C, et al
    Training Community Health Workers to Manage Uncomplicated and Severe Malaria: Experience From 3 Rural Malaria-Endemic Areas in Sub-Saharan Africa.
    Clin Infect Dis. 2016;63.
    PubMed     Abstract available


  127. CASTELLANI J, Nsungwa-Sabiiti J, Mihaylova B, Ajayi IO, et al
    Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs.
    Clin Infect Dis. 2016;63.
    PubMed     Abstract available


  128. AJAYI IO, Nsungwa-Sabiiti J, Siribie M, Falade CO, et al
    Feasibility of Malaria Diagnosis and Management in Burkina Faso, Nigeria, and Uganda: A Community-Based Observational Study.
    Clin Infect Dis. 2016;63.
    PubMed     Abstract available


    October 2016
  129. SONDEN K, Wyss K, Jovel I, Vieira da Silva A, et al
    High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series.
    Clin Infect Dis. 2016.
    PubMed     Abstract available


    May 2016
  130. PARIKH S, Kajubi R, Huang L, Ssebuliba J, et al
    Antiretroviral choice for HIV impacts antimalarial exposure and treatment outcomes in Ugandan children.
    Clin Infect Dis. 2016.
    PubMed     Abstract available


    April 2014
  131. KAKURU A, Jane A, Muhindo M, Ikilezi G, et al
    Artemisinin-based Combination Therapies are Efficacious and Safe for Treatment of Uncomplicated Malaria in HIV-infected Ugandan Children.
    Clin Infect Dis. 2014.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: